Marc Besman Ph.D., joined Kronos Bio in 2023 as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance. Dr. Besman brings more than 25 years of biopharmaceutical experience to Kronos Bio, where he is responsible for developing, implementing, and advancing global regulatory strategies for Kronos Bio’s portfolio. He also ensures that the Company upholds the highest levels of clinical quality compliance. Dr. Besman joins Kronos Bio from Coherus BioSciences where he served as Senior Vice President of Regulatory Affairs. While at Coherus BioSciences, he built out the regulatory affairs function and helped to advance the Company’s oncology development programs. Previously, including at CytomX Therapeutics, Inc., Allergan, CTI Seattle and Baxter BioSciences, Dr. Besman held a series of leadership roles in regulatory affairs, development, and program management. Dr. Besman received a B.Sc. Honours in Chemistry with Biochemistry from the University of Southampton (UK) and a M.Phil. and Ph.D. in Biochemistry from Yale University, and he pursued a post-doctoral fellowship at the City of Hope, California.